Michael Mason

2020

In 2020, Michael Mason earned a total compensation of $2.3M as Senior Vice President, Chief Financial Officer and Treasurer at Karyopharm Therapeutics, a 137% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$156,123
Option Awards$1,096,226
Salary$415,624
Stock Awards$586,963
Other$11,880
Total$2,266,816

Mason received $1.1M in option awards, accounting for 48% of the total pay in 2020.

Mason also received $156.1K in non-equity incentive plan, $415.6K in salary, $587K in stock awards and $11.9K in other compensation.

Rankings

In 2020, Michael Mason's compensation ranked 4,967th out of 13,090 executives tracked by ExecPay. In other words, Mason earned more than 62.1% of executives.

ClassificationRankingPercentile
All
4,967
out of 13,090
62nd
Division
Manufacturing
2,023
out of 5,618
64th
Major group
Chemicals And Allied Products
802
out of 2,251
64th
Industry group
Drugs
692
out of 1,951
65th
Industry
Pharmaceutical Preparations
520
out of 1,456
64th
Source: SEC filing on April 7, 2021.

Mason's colleagues

We found two more compensation records of executives who worked with Michael Mason at Karyopharm Therapeutics in 2020.

2020

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2020

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

News

You may also like